Botanical species · safety record

Fallopia japonica

The EFSA Compendium of Botanicals holds 9 constituent measurements for Fallopia japonica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fallopia japonica (Houtt.) Ronse Decr.

9Constituent measurements
0Safety records
2Cited sources
54Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 54 licensed products naming Fallopia japonica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Extract Type TBA

Source material stated

  • Fallopia japonica
  • Fallopia japonica - Root
  • New material
  • Rhizome
  • Root
  • Root (standardized extract)
  • Root extract
  • Root extract (standardised)

What the records describe

Constituents measured

  • Chrysophanol2
  • Emodin2
  • Physcion2
  • Rhein2
  • Aloe-emodin1

Plant parts

  • Roots and other underground parts9

Preparations

  • Powder5
  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Aloe-emodinRoots and other underground partsPowder12.7 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
ChrysophanolRoots and other underground partsPowder7.68 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
EmodinRoots and other underground partsPowder2120 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
PhyscionRoots and other underground partsPowder1460 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
RheinRoots and other underground partsPowder46.5 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
ChrysophanolRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
EmodinRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
PhyscionRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
RheinRoots and other underground partsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yan, Yunyan., Chen, Xuan., Hu, Shuang., Tian, Jie., Bai, Xiaohong. Simultaneous Preconcentration and Analysis of Anthraquinones Based on Ultrasound Emulsification Ionic Liquid Microextraction . Journal of chromatographic science, 2014, vol. 52, no. 3, p. 218-225. DOI
  2. Luo, Jian-ming., Huang, Qing-song., Li, Tao. Determination of rhein, emodin, chrysophanol and physcion contents in Polygonum cuspidatum root by HPLC. Zhongyaocai, 2012, p. 736-738.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue